SUMMIT, N.J.--(BUSINESS WIRE) June 06, 2019 -- Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application for ozanimod for the treatment of people with... (Source: - New Drug Applications)

Read full article on

Powered by Preisvergleich


Follow Us on Twitter

Follow Us On Twitter - Image